Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment
- 1 December 2001
- journal article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 189 (3) , 356-365
Abstract
While extracellular acidification within solid tumors is well‐documented, how reduced pH impacts regulation of insulin‐like growth factor‐I (IGF‐I) has not been studied extensively. Because IGF‐I receptor binding is affected by IGF binding proteins (IGFBPs), we examined how pH impacted IGFBP‐3 regulation of IGF‐I. IGF‐I binding in the absence of IGFBP‐3 was diminished at reduced pH. Addition of IGFBP‐3 reduced IGF‐I cell binding at pH 7.4 but increased surface association at pH 5.8. This increase in IGF‐I binding at pH 5.8 corresponded with an increase in IGFBP‐3 cell association. This, however, was not due to an increase in affinity of IGFBP‐3 for heparin at reduced pH although both heparinase III treatment and heparin addition reduced IGFBP‐3 enhancement of IGF‐I binding. An increase in IGF‐I binding to IGFBP‐3, though, was seen at reduced pH using a cell‐free assay. We hypothesize that the enhanced binding of IGF‐I at pH 5.8 is facilitated by increased association of IGFBP‐3 at this pH and that the resulting cell associated IGF‐I is IGFBP‐3 and not IGF‐IR bound. Increased internalization and nuclear association of IGF‐I at pH 5.8 in the presence of IGFBP‐3 was evident, yet cell proliferation was reduced by IGFBP‐3 at both pH 5.8 and 7.4 indicating that IGFBP‐3‐cell associated IGF‐I does not signal the cell to proliferate and that the resulting transfer of bound IGF‐I from IGF‐IR to IGFBP‐3 results in diminished proliferation. Solution binding of IGF‐I by IGFBP‐3 is one means by which IGF‐I‐induced proliferation is inhibited. Our work suggests that an alternative pathway exists by which IGF‐I and IGFBP‐3 both associate with the cell surface and that this association inhibits IGF‐I‐induced proliferation.Keywords
This publication has 59 references indexed in Scilit:
- The Insulin-like Growth Factor-Phosphatidylinositol 3-Kinase-Akt Signaling Pathway Regulates Myogenin Expression in Normal Myogenic Cells but Not in Rhabdomyosarcoma-derived RD CellsJournal of Biological Chemistry, 2000
- Insulin-like growth factor binding protein-3 mediates IGF-I action in a bovine mammary epithelial cell line independent of an IGF interactionJournal of Cellular Physiology, 2000
- Oncogenic ras Causes Resistance to the Growth Inhibitor Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) in Breast Cancer CellsJournal of Biological Chemistry, 1999
- Measurement of insulin-like growth factor (IGF)-II binding to purified IGF binding proteins 1–6: comparison of charcoal adsorption and high performance size exclusion chromatographyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Characterization of transforming growth factor‐β growth regulatory effects and receptors on bovine mammary cellsJournal of Cellular Physiology, 1995
- The role of glycosylation in the action of IGFBP-3Progress in Growth Factor Research, 1995
- Identification of the major sites of phosphorylation in IGF binding protein‐3Journal of Cellular Biochemistry, 1994
- IGF-I-Induced IGFBP-3 potentiates the mitogenic actions of IGF-I in mammary epithelial MD-IGF-I cellsMolecular and Cellular Endocrinology, 1994
- Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparinBiochemistry, 1993
- Receptor binding and growth-promoting activity of insulin-like growth factor-I in a bovine mammary epithelial cell line (MAC-T3)Journal of Endocrinology, 1992